Skip to main content

Table 4 Response to chemotherapy (n = 402)

From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

Response

No of Patient

%

CR

25

6.2

PR

120

29.9

SD

140

34.8

PD

103

25.6

ORR (CR + PR)

145

36.1

DCR (CR + PR + SD)

285

70.9

NE

14

3.5

Total

402

100.0

  1. CR: complete response, PR: partial response, SD: stable disease, PD: progressive disease, ORR: overall response rate, DCR: disease control rate, NE: not evaluable